Webinar on Demand #11
"*" indicates required fields
severe pain fast for an average
of 8 hours(1)
for severe pain relief
delivers up to 24 hours of relief(1)
treatment may deliver up to
72 hours of pain relief(1)
frequency peripheral
nerve stimulation
electrode garments can treat
up to a 6X larger volume
of tissue and deliver
immediate and long-lasting
relief from pain
severe pain fast for up to 8 hours1
for severe pain relief
delivers up to 24 hours of relief1
treatment may deliver up to
72 hours of pain relief1
frequency peripheral
nerve stimulation
electrode garments can treat 5X
larger volume of tissue and deliver
immediate and long-lasting
relief from pain
A smarter way to relieve severe pain
BioWave®’s patented, high-frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve and blocking transmission of pain signals to the brain. BioWave®’s active electrical field reduces pain and increases range of motion and function—8 hours on average and for many patients up to 24 hours following a 30-minute treatment(1). BioWave® is a 100% drug-free, wearable, FDA cleared and CE certified, smarter pain blocking technology.®
Wearable, comfortable and easy-to-use
Our non-invasive devices require no programming and have electrodes that can be easily placed over location of pain. Patients control intensity and comfort levels with a plus/minus button. Because treatments create a pleasantly deep, smooth sensation, patient compliance is excellent.
BioWave goes deeper
BioWave’s patented high frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve, blocking the transmission of pain signals to the brain.
BioWave
Innovative deep relief
TENS
Antiquated shallow reach
94%
of patients reported an improvement in quality of life after using BioWave for two weeks (1)
8 hours
of pain relief on
average following
a 30-minute treatment(1)
3.47 points
average reduction in pain score (0-10 scale) after using BioWave for two weeks(2)
54%
of patients reduced or eliminated their pain medication consumption after using BioWave for two weeks(1)
(1) Open Label Pilot Study Investigating Non invasive High-Frequency Peripheral Nerve Fiber Stimulation In Chronic Pain Patients. Outcomes from 463 study participants, published in the peer reviewed journal Pain Practice from the World Institute of Pain.
(2) Reduced Pain and Improved Function Following Short-Term Use of Noninvasive BioWave High-Frequency Peripheral Nerve Stimulation for Pain Management. Open-label survey of 1,511 chronic pain patients recruited from Veteran Affairs, orthopedic and pain health systems, published in the peer reviewed journal Pain and Therapy.
Featured in clinical trials for osteoarthritis pain treatment
Brian J. Cole, MD, MBA; Richard Kang, MD, MS; Paul 8. Lewis, MD, MS; Adam Kramer, ATC; Jennifer K. Hayden, RN, MSN; Randomized Single-blinded Controlled Clinical Trial of a BiowavePENS device (Percutaneous Electrical Nerve Stimulation) versus Sham PENS treatment for the Osteoarthritic Knee. Orthopedics, June 2007, Volume 30, Number 6.
Results that change and improve daily life
BioWave brings better patient outcomes and higher levels of satisfaction than competing pain treatments. Patients find they feel better and do more.
- Increase walking distances
- Reduce VAS pain scores
- Increase ADL’s
- Get a better night’s sleep
- Lower pain med consumption
The following data was compiled from patient surveys collected two or more weeks after the patient received their BioWave device.
Featured On
